On 11 November, Minister for Social Services Camilla Waltersson Grönvall visited the Swedish Childhood Tumor Biobank at Karolinska Institutet. The visit was arranged in collaboration with the Swedish Childhood Cancer Fund and provided insight into how samples and data from children with cancer are used in diagnostics and research, and how they can help develop new treatments.

Camilla Waltersson Grönvall has previously raised issues relating to childhood cancer. As a member of the Swedish Parliament, she highlighted, among other things, the need for a national childhood cancer strategy.
The Swedish Childhood Tumor Biobank is a national sample collection and research infrastructure that collects, analyses and makes available biological samples and associated data for research.Through collaboration with the country's childhood cancer centres, researchers gain access to material that can increase knowledge about childhood cancer and help improve diagnosis and treatment.
Had the opportunity to follow the sample's journey
The visit took place in the BioClinicum research building at Karolinska University Hospital in Solna. Based on de-identified patient cases, the minister followed the journey of the samples, from sampling and diagnosis to processing, molecular analyses and storage, and on to research.
The minister also saw how childhood cancer samples can be combined with clinical data, digital pathology images and multiple large-scale genetic and molecular analysis datasets to provide a more detailed picture of the disease and, in the future, improve prognosis and enable more precise and targeted treatments with fewer side effects and improved survival.

- The Swedish Childhood Tumor Biobank is a population-based research resource in the field of childhood cancer, with extensive national collaboration. It is very valuable for us that policymakers can gain a concrete insight into our work and also see the progress being made in the field. Research infrastructures are important for further innovation and for implementing precision medicine in healthcare, says Johanna Sandgren , head of the Swedish Childhood Tumor Biobank .
Discussion on the conditions for research
The visit concluded with a round-table discussion on the conditions for continued development in the field of childhood cancer. The agenda included long-term funding for research infrastructure, opportunities to share and use health data, and how research advances and precision medicine initiatives can benefit children with cancer.
The Department of Oncology-Pathology at Karolinska Institutet is the host department for the Swedish Childhood Tumor Biobank. The sample collection belongs to Clinical Pathology and Cancer Diagnostics at Karolinska University Hospital.